title: Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity.
abstract: A unique feature of human alveolar macrophages is their prolonged survival in the face of a stressful environment. We have shown previously that the ERK MAPK is constitutively active in these cells and is important in prolonging cell survival. This study examines the role of the ERK pathway in maintaining mitochondrial energy production. The data demonstrate that ATP levels in alveolar macrophages depend on intact mitochondria and optimal functioning of the electron transport chain. Significant levels of MEK and ERK localize to the mitochondria and inhibition of ERK activity induces an early and profound depletion in cellular ATP coincident with a loss of mitochondrial transmembrane potential. The effect of ERK suppression on ATP levels was specific, since it did not occur with PI3K/Akt, p38, or JNK suppression. ERK inhibition led to cytosolic release of mitochondrial proteins and caspase activation. Both ERK inhibition and mitochondrial blockers induced loss of plasma membrane permeability and cell death. The cell death induced by ERK inhibition had hallmarks of both apoptotic (caspase activation) and necrotic (ATP loss) cell death. By blocking ERK inhibition-induced reactive oxygen species, caspase activation was prevented, although necrotic pathways continued to induce cell death. This suggests that mitochondrial dysfunction caused by ERK inhibition generates both apoptotic and necrotic cell death-inducing pathways. As a composite, these data demonstrate a novel mitochondrial role for ERK in maintaining mitochondrial membrane potential and ATP production in human alveolar macrophages.
authors.affiliation: Department of Medicine, University of Iowa Carver College of Medicine and Veterans Administration Medical Center, Iowa City, IA 52242, USA. martha-monick@uiowa.edu
authors.forename: Martha M
authors.initials: MM
authors.lastname: Monick
authors.forename: Linda S
authors.initials: LS
authors.lastname: Powers
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Barrett
authors.forename: Sara
authors.initials: S
authors.lastname: Hinde
authors.forename: Alix
authors.initials: A
authors.lastname: Ashare
authors.forename: Dayna J
authors.initials: DJ
authors.lastname: Groskreutz
authors.forename: Toru
authors.initials: T
authors.lastname: Nyunoya
authors.forename: Mitchell
authors.initials: M
authors.lastname: Coleman
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Spitz
authors.forename: Gary W
authors.initials: GW
authors.lastname: Hunninghake
mesh_terms: D000251:Adenosine Triphosphatases / Q000276:immunology / Q000378:metabolism*; D002478:Cells, Cultured; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D006801:Humans; D016676:Macrophages, Alveolar / Q000276:immunology / Q000378:metabolism* / Q000648:ultrastructure; D046529:Microscopy, Electron, Transmission; D008928:Mitochondria / Q000276:immunology / Q000378:metabolism*; D010587:Phagocytosis; D017382:Reactive Oxygen Species / Q000378:metabolism*
chemical_list: D017382:Reactive Oxygen Species; D048049:Extracellular Signal-Regulated MAP Kinases; D000251:Adenosine Triphosphatases